Under the new service contract, Accretive will exclusively provide revenue cycle services and physician advisory services to Ascension’s hospitals. A newly formed investment vehicle — owned by Ascension and TowerBrook Capital Partners — has invested $200 million in Accretive Health, in exchange for convertible preferred stock and warrants.
Accretive Health expects to begin transitioning Ascension’s hospitals to the new service agreement over the next six months.
“Ascension has been a valued partner since the founding of the company and we are pleased to enter a new phase in our relationship as long-term strategic partners,” said Emad Rizk, MD, president and CEO of Accretive Health. “The highly complementary relationship with Ascension provides us with a significant growth trajectory, and we look forward to the benefits it will deliver to our customers, our employees and our shareholders.”
The two companies announced the transaction Dec. 8 of last year.
More articles on revenue cycle management:
Patients fronting cash for medical bills are getting big discounts: 7 things to know
In pay-for-performance, are hospitals unfairly penalized for patient hardships?
Financial pains of patient accounting systems felt most in the first three months: 7 findings
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
